Commentary: multimodal assessment of medication adherence among youth with migraine: an ancillary study of the CHAMP trial

Ryan D. Parsons*, Joanna McParland, Abbie Jordan

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Migraine headaches are experienced by approximately 6 million young people in the United States and often result in associated disability (Powers et al., 2021). While the management of migraine headaches regularly involves the use of medication (Silberstein & Goadsby, 2002), little is known about adherence to medication among young people (Ramsey et al., 2014). Responding to this knowledge gap, Reidy et al. (this issue) provide a US-based systematic, multi-modal investigation of adherence in a sample of 328 participants aged 8–17 years. Participants were recruited into the Child and Adolescent Migraine Prevention clinical trial. Adherence was measured over a 6-month period, using subjective and objective monthly measures. Measures included pill counts, self-report daily diary data, and drug serum levels at months’ 3 (end of titration period) and 6 (end of trial). Participants were required to take two pills daily and were randomly assigned either Topiramate,...
Original languageEnglish
Pages (from-to)388-390
Number of pages3
JournalJournal of Pediatric Psychology
Volume47
Issue number4
Early online date19 Feb 2022
DOIs
Publication statusPublished - May 2022

Keywords

  • adherence/self-management
  • adolescents
  • clinical trial
  • headache and migraine

ASJC Scopus subject areas

  • Developmental and Educational Psychology
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Commentary: multimodal assessment of medication adherence among youth with migraine: an ancillary study of the CHAMP trial'. Together they form a unique fingerprint.

Cite this